Cargando…

Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients

BACKGROUND: There is increasing evidence that immunotherapy with nivolumab, an anti‐programmed death 1 monoclonal antibody, is effective in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). However, the predictive role of hematological inflammatory ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuki, Takashi, Okamoto, Isaku, Fushimi, Chihiro, Sawabe, Michi, Kawakita, Daisuke, Sato, Hiroki, Tsukahara, Kiyoaki, Kondo, Takahito, Okada, Takuro, Tada, Yuichiro, Miura, Kouki, Omura, Go, Yamashita, Taku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367642/ https://www.ncbi.nlm.nih.gov/pubmed/32441463 http://dx.doi.org/10.1002/cam4.3124

Ejemplares similares

Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients
por: Matsuki, Takashi, et al.
Publicado: (2020)

Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma—A Multicenter Retrospective Study
por: Tokashiki, Kunihiko, et al.
Publicado: (2022)

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
por: Niwa, Kazutomo, et al.
Publicado: (2020)

Single-center prospective study on the efficacy of nivolumab against platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma
por: Okamoto, Isaku, et al.
Publicado: (2022)

Photoimmunotherapy for Managing Recurrent Laryngeal Cancer Cervical Lesions: A Case Report
por: Okamoto, Isaku, et al.
Publicado: (2022)

Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
por: Okamoto, Isaku, et al.
Publicado: (2022)

Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
por: Kawakita, Daisuke, et al.
Publicado: (2016)

The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy
por: Saigusa, Natsuki, et al.
Publicado: (2022)

A Case of Oropharyngeal Carcinoma with an Oblique Neck that Benefited from Transoral Robotic Surgery
por: Yamakura, Tatsuya, et al.
Publicado: (2023)

Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise
por: Ito, Tatsuya, et al.
Publicado: (2021)

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022)

A Case of Septicemia due to Nonocclusive Mesenteric Ischemia Occurring in Induction Chemotherapy
por: Tanaka, Hideki, et al.
Publicado: (2018)

The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma
por: Hirai, Hideaki, et al.
Publicado: (2020)

Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling
por: Kohsaka, Shinji, et al.
Publicado: (2022)

Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma
por: Sato, Hiroki, et al.
Publicado: (2018)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2020)

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma
por: Fushimi, C, et al.
Publicado: (2018)

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification
por: Takase, Soichiro, et al.
Publicado: (2017)

Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma
por: Matsuzuka, Takashi, et al.
Publicado: (2023)

Abstract: Utility of Creating Surgical Guide Using Sterilizable and Inexpensive Dental Impression Silicon in Free Fibula Flap Mandibular and Maxillary Bone Reconstruction
por: Matsui, Chihiro, et al.
Publicado: (2018)

Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature
por: Ohara, Nobumasa, et al.
Publicado: (2019)

Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
por: Shimura, Tomotaka, et al.
Publicado: (2017)

Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients
por: Otsuka, Kuninori, et al.
Publicado: (2016)

Preoperative Evaluation of Substernal Goiter by Computed Tomography in the Extended Neck Position
por: Yano, Teruhisa, et al.
Publicado: (2021)

Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: A prospective study
por: Sawabe, Michi, et al.
Publicado: (2017)

The Heterogeneous Impact of Prediagnostic Folate Intake for Fluorouracil-Containing Induction Chemotherapy for Head and Neck Cancer
por: Sawabe, Michi, et al.
Publicado: (2023)

The risks of hematological toxicities of nivolumab in cancer patients: A PRISMA-compliant meta-analysis
por: Shi, Zuolin, et al.
Publicado: (2022)

Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment
por: Tada, Kouki, et al.
Publicado: (2022)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study
por: Okumura, Yoshihide, et al.
Publicado: (2020)

The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study
por: Nishiyama, Naotaka, et al.
Publicado: (2020)

Attempting to define sentinel node micrometastasis in oral squamous cell carcinoma
por: Matsuzuka, Takashi, et al.
Publicado: (2020)

Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient
por: Abe, Jiro, et al.
Publicado: (2016)

Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)
por: Ishiwata, Tsukasa, et al.
Publicado: (2017)

Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis
por: Kudo, Fumiaki, et al.
Publicado: (2018)

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630
por: Taniguchi, Yuri, et al.
Publicado: (2022)

EXM-88-01: 10/03/88
por: Martucci, P, et al.
Publicado: (1988)

EXM-88-02: 17/03/88
por: Martucci, P
Publicado: (1988)

Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
por: Khunger, Monica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_odaf2fft0o7honkulmbskp8rbk